FDA-approved branded GLP-1 therapy — Wegovy (semaglutide) and Zepbound (tirzepatide) — with board-certified medical supervision. $99 initial visit. Prescription sent directly to manufacturer savings programs. Telehealth in MD, VA & FL.
GLP-1 receptor agonists (glucagon-like peptide-1) are a class of medications originally developed for type 2 diabetes that have revolutionized medical weight management. They work by mimicking hormones your body naturally produces after eating — slowing digestion, reducing hunger signals, and helping you feel full with less food.
The results are clinically dramatic. Clinical trials show average weight loss of 15–22% of body weight over 68 weeks with semaglutide (Wegovy) and tirzepatide (Zepbound). These aren't stimulants or crash diet pills — they're sophisticated metabolic medicines that change how your brain and gut regulate appetite.
At Icon Medicine, you get ongoing medical monitoring, dose adjustments, lifestyle guidance, and a real relationship with your provider — all via telehealth. We prescribe the branded FDA-approved medications and send your prescription directly to the manufacturer's savings program for fulfillment.
$75/mo follow-up visits · Medication billed separately by manufacturer
Medical eligibility is based on clinical criteria. Most people who have struggled with weight despite diet and exercise qualify.
Standard clinical qualification for GLP-1 therapy. No additional health conditions required.
Overweight with type 2 diabetes, hypertension, high cholesterol, or sleep apnea.
You've tried diets and exercise programs. You may need medical support to overcome metabolic resistance.
GLP-1 medications also improve blood sugar control. Many reduce or eliminate other diabetes medications with sustained weight loss.
Need to lose weight before elective surgery, joint replacement, or other procedures where weight reduction reduces surgical risk.
Don't have time for in-person clinic visits. Our 100% telehealth model means your care fits your schedule.
We follow evidence-based clinical protocols for GLP-1 therapy with the personal attention of a private practice.
45-minute telehealth visit covering medical history, current medications, lab work review, and discussion of your weight history and goals. We determine which GLP-1 medication is right for you based on your health profile, insurance coverage, and goals.
We send your Wegovy or Zepbound prescription to the manufacturer's savings program — NovoCare (Wegovy) or Lilly Direct (Zepbound). They contact you directly, process payment, and ship your medication. Self-pay pricing starts as low as $149/mo for Wegovy and $299/mo for Zepbound. With insurance, your cost may be significantly lower.
GLP-1 medications use a slow escalation schedule (4 weeks per dose level) to find your optimal therapeutic dose. Monthly check-ins ensure you're tolerating the medication and seeing results. Most patients reach their target dose by month 4–5.
Monthly telehealth visits to track weight, review labs, assess side effects, and adjust your plan. We also provide practical nutrition and activity guidance — not a rigid diet, but sustainable changes that complement the medication.
Once you reach your goal, we discuss a maintenance strategy. Some patients continue at a lower dose; others transition to lifestyle-only maintenance. We monitor for weight regain and adjust proactively.
Ready to Start?
Board-certified providers · Licensed in MD, VA & FL · HIPAA-compliant telehealth
Realistic expectations are part of good medicine.
Best results come when combined with:
Maryland: Telehealth or in-person at 7411 Riggs Rd, Suite 300B, Hyattsville.
VA & FL: Telehealth only. Initial visit 45 min; monthly follow-ups 15–20 min. Labs ordered to a facility near you.
Other telehealth weight loss programs charge more and give you less.
$99 initial visit. $75/month follow-ups. Medication is billed directly by NovoCare (Wegovy) or Lilly Direct (Zepbound) — no markup, no hidden program fees.
Not a mid-level provider on a weight loss assembly line. Our board-certified physicians manage your care personally.
We treat the whole person — diabetes, hypertension, mental health concerns are addressed alongside your weight goals.
GLP-1 medications can be expensive. We assist with prior authorization and savings programs to reduce your out-of-pocket cost.
No required meal plans, supplements, or $500 "starter kits." Just real medicine, real monitoring, and honest guidance.
Same-day telehealth appointments available. Book online or call — your first visit can happen today.
From the Blog
GLP-1 Weight Loss Treatment: Telehealth Options in Virginia — A deep dive into how GLP-1 medications like Wegovy and Zepbound work, who qualifies, and what real patients experience.
GLP-1 medications (Wegovy & Zepbound) are FDA-approved for BMI ≥ 30, or BMI ≥ 27 with a weight-related condition. Calculate yours and see your projected results.
Enter your measurements — results appear instantly. Add your email to get results in your inbox.
Standard WHO / NIH classification for adults 20+
| BMI Range | Category | GLP-1 Eligible |
|---|---|---|
| Below 18.5 | Underweight | — |
| 18.5 – 24.9 | Normal Weight | — |
| 25.0 – 29.9 | Overweight | ✓ w/ conditions |
| 30.0 – 34.9 | Obese Class I | ✓ Eligible |
| 35.0 – 39.9 | Obese Class II | ✓ Eligible |
| 40.0 and above | Obese Class III | ✓ Eligible |
GLP-1 eligibility (Wegovy/Zepbound) at BMI 27–29 requires at least one weight-related condition. BMI is a screening tool — clinical eligibility confirmed at provider evaluation.
Based on GLP-1 clinical trial outcomes (STEP & SURMOUNT trials)
*Average clinical trial outcomes at maximum tolerated doses. Individual results vary. Not a guarantee of results. All treatments require provider evaluation.
The most common questions we get about Wegovy and Zepbound weight management.
Coverage varies. Many commercial plans cover Wegovy and Zepbound for weight management. We help with prior authorization — and for patients without coverage, manufacturer savings programs (NovoCare for Wegovy, Lilly Direct for Zepbound) can significantly reduce medication cost. We'll discuss all options at your first visit.
Clinical trials show 15–22% total body weight loss over 68 weeks with semaglutide and tirzepatide at maximum doses. That's 30–44 lbs for a 200-lb person. Real-world results vary — most patients see meaningful results within the first 3 months.
Studies show stopping GLP-1 medications typically leads to regaining about 2/3 of lost weight within a year. This is why we view obesity as a chronic medical condition requiring long-term management. We discuss maintenance strategies early so you're not blindsided if you decide to stop.
GLP-1 medications have been used for type 2 diabetes since 2005 and have extensive safety data. Semaglutide (Wegovy) has been studied in over 17,000 patients showing reduced heart attack and stroke risk. Contraindications include personal/family history of medullary thyroid cancer, MEN2 syndrome, or prior pancreatitis. We screen for all contraindications at your evaluation.
No crash diets or proprietary meal plans. The medication significantly reduces appetite. We provide guidance emphasizing protein, hydration, and manageable activity. Most patients naturally gravitate toward smaller portions and better food choices.
You pay Icon Medicine $99 for your initial visit and $75/month for follow-up appointments. Medication is billed separately by the manufacturer's savings program — NovoCare for Wegovy, Lilly Direct for Zepbound. Self-pay pricing starts at $149/mo for Wegovy pill, $349/mo for Wegovy pen, and $299/mo for Zepbound. With insurance or savings programs, your cost may be significantly lower. Call (240) 966-4266 to discuss options.
Yes — Icon Medicine prescribes Wegovy (semaglutide) and Zepbound (tirzepatide) via telehealth for Maryland patients. No in-person visit required. Book a telehealth weight management evaluation, and if you're a candidate, receive your prescription the same day. VA and FL telehealth patients are also eligible.
Both are highly effective branded GLP-1 medications. Wegovy (semaglutide) targets the GLP-1 hormone receptor. Zepbound (tirzepatide) is a dual GIP/GLP-1 agonist — it targets two hormone receptors instead of one. Clinical trials show tirzepatide produces slightly greater average weight loss (up to 22% body weight) versus semaglutide (up to 15–17%). Your provider will recommend the best option based on your medical history, goals, and insurance coverage.
If several of these apply, you're likely a strong candidate. A brief consultation will confirm eligibility — no obligation.
BMI ≥ 30, or BMI ≥ 27 with a weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea)
You've tried multiple diets and exercise programs but can't maintain weight loss long-term
Hunger and food cravings feel difficult to control even when you're strongly motivated to eat less
Excess weight affects your energy, joint pain, sleep quality, mood, or self-confidence
You have type 2 diabetes or prediabetes and want to reduce medication dependence through weight loss
You want a telehealth approach — no weigh-ins at a clinic, no mandatory meal plans or supplements
If 2 or more apply to you, it's worth a conversation.
Same-day appointments available. Book online or call (240) 966-4266. Book a free eligibility check →
Transparent visit fees. Medication billed directly by the manufacturer — no markup, no hidden program fees.
Medication cost is billed separately by NovoCare (Wegovy) or Lilly Direct (Zepbound). We assist with prior authorization and savings program enrollment to minimize your out-of-pocket cost.
Pricing is available for local pharmacy pickup with a savings offer or home delivery. New patient limited-time offers available through NovoCare.
Self-pay pricing through Lilly Direct. Prices reflect monthly cost with the Zepbound Self Pay Journey Program.
Prefer an oral pill over injections? FDA-approved appetite suppressants are an effective, affordable alternative for qualified Maryland patients. Telehealth prescription — medication filled at your local pharmacy.
Appetite suppressants work directly on the brain's hunger and reward signaling pathways. Unlike GLP-1 injections that mimic gut hormones, these FDA-approved oral medications reduce hunger signals at the neurological level — making it significantly easier to eat less without the mental battle.
They're an excellent option for patients who want to avoid injections, prefer a lower-cost oral medication, or have tried GLP-1 therapy and are looking for an alternative approach.
All prescriptions require a medical evaluation to confirm eligibility, rule out contraindications, and select the right medication for your health profile.
Appetite Suppressant Pricing
Comprehensive evaluation, medical history review, lab orders if needed, medication selection
Ongoing telehealth check-ins, medication management, provider messaging
Filled at your local Maryland pharmacy. Insurance may cover medication cost.
✓ No hidden fees · ✓ No enrollment fee · ✓ Cancel anytime
Your provider will determine the best fit based on your medical history, goals, and preferences. Here's how they compare:
Icon Medicine Advantage: Our providers have addiction medicine expertise — a unique background for managing Contrave (naltrexone/bupropion), since naltrexone originates in addiction pharmacology. This means deeper clinical knowledge of how this medication works and more nuanced prescribing decisions.
Standard FDA criteria apply. Most patients who have struggled with weight despite diet and exercise will qualify.
Standard obesity classification. No additional health conditions required to qualify.
Overweight + type 2 diabetes, hypertension, high cholesterol, or sleep apnea qualifies under FDA criteria.
Great for patients who want to avoid injectables, or are looking for an affordable alternative to GLP-1 therapy.
From evaluation to prescription — all via telehealth, all in Maryland.
$99 Initial Visit
Comprehensive medical review of your history, current medications, labs, and weight goals. We screen for contraindications and determine which medication — Phentermine or Contrave — is the right fit for your profile.
Provider Decision
Your board-certified provider selects the appropriate medication and dosing based on your health profile. Prescription is sent electronically to your chosen local Maryland pharmacy.
Your Local Pharmacy
Pick up your medication at any local pharmacy. Insurance may cover your medication cost — we can advise on coverage and savings programs during your visit.
$75/mo Ongoing
Monthly check-ins to monitor progress, manage side effects, adjust dosing, and provide ongoing support. Direct provider messaging between visits.
Telehealth appointments available statewide — Hyattsville, Baltimore, Rockville, Silver Spring, Annapolis, and everywhere in between. No driving, no waiting rooms.
Optional in-person visits at our Hyattsville office: 7411 Riggs Rd, Suite 300B, Hyattsville, MD 20783 — for patients who prefer face-to-face care.
Board-Certified Providers — Not a mid-level assembly line. Real physicians managing your care personally.
Addiction Medicine Expertise — Unique clinical background for Contrave (naltrexone). Deeper pharmacology knowledge than typical weight loss clinics.
Ongoing Medical Supervision — Monthly follow-ups, not a one-time Rx and goodbye. We monitor your progress, labs, and side effects continuously.
Affordable & Transparent — $99 initial visit, $75/mo follow-ups. No enrollment fees, no hidden costs, cancel anytime.
Start Your Weight Loss Journey Today
Telehealth appointment available statewide in Maryland. Board-certified provider. Prescription sent to your local pharmacy. Monthly follow-ups at $75/mo.
Real experiences from Icon Medicine patients. Their words, not ours.
I had tried every diet imaginable. Three months into semaglutide with Icon Medicine and I've lost 24 pounds. The cravings just disappeared. I finally feel in control of what I eat.
Sarah M.
Maryland patient · GLP-1 Weight Management
The telehealth model made this possible for me. I work two jobs — I can't make clinic appointments. Everything from the visit to the pharmacy prescription happened in one afternoon. Down 31 pounds in 5 months.
David K.
Virginia patient · Semaglutide Therapy
My A1C dropped from 7.8 to 6.2 and I've lost 38 pounds. My cardiologist was genuinely surprised. The price is so much more reasonable than every other GLP-1 program I looked at.
Linda R.
Maryland patient · Diabetes + Weight Management
* Patient names changed for privacy. Testimonials represent typical patient experiences; individual results may vary.
Real medicine, real results. Book your $99 initial visit and get started with Wegovy or Zepbound — prescribed by board-certified providers, fulfilled through manufacturer savings programs.
7411 Riggs Rd, Suite 300B, Hyattsville, MD 20783 | Fax: (301) 235-1771
Legal Disclaimers